|
|
Volumn 485, Issue 7400, 2012, Pages 582-
|
|
Biologics: Personalized drugs should cut care costs
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BIOLOGICAL MARKER;
BIOSIMILAR AGENT;
AGING;
COST CONTROL;
DRUG COST;
DRUG EFFICACY;
DRUG SAFETY;
EUROPEAN UNION;
FUNDING;
GENETIC ANALYSIS;
GOVERNMENT;
LETTER;
PERSONALIZED MEDICINE;
PRESCRIPTION;
PRIORITY JOURNAL;
ECONOMICS;
GENE EXPRESSION PROFILING;
HEALTH CARE COST;
HUMAN;
METHODOLOGY;
STATISTICS;
UTILIZATION REVIEW;
BIOLOGICAL MARKERS;
BIOSIMILAR PHARMACEUTICALS;
GENE EXPRESSION PROFILING;
HEALTH CARE COSTS;
HUMANS;
INDIVIDUALIZED MEDICINE;
|
|
EID: 84863745996
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/485582b Document Type: Letter |
|
Times cited : (2)
|
|
References (0)
|
